acrolein has been researched along with Urinary Tract Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brock, N; Niemeyer, U; Pohl, J; Scheffler, G; Stekar, J | 1 |
| Loehrer, PJ; Munshi, NC; Williams, SD | 1 |
1 review(s) available for acrolein and Urinary Tract Diseases
| Article | Year |
|---|---|
Uroprotection in patients receiving cyclophosphamide and ifosfamide.
Topics: Acrolein; Cyclophosphamide; Humans; Ifosfamide; Sulfhydryl Compounds; Urinary Tract; Urologic Diseases | 1991 |
1 other study(ies) available for acrolein and Urinary Tract Diseases
| Article | Year |
|---|---|
Acrolein, the causative factor of urotoxic side-effects of cyclophosphamide, ifosfamide, trofosfamide and sufosfamide.
Topics: Acrolein; Aldehydes; Animals; Cyclophosphamide; Cystitis; Female; Ifosfamide; Inactivation, Metabolic; Kidney; Male; Mesna; Rats; Urinary Bladder; Urinary Tract; Urologic Diseases | 1979 |